5α-Hydroxycostic acid inhibits choroidal neovascularization in rats through a dual signalling pathway mediated by VEGF and angiopoietin 2.
Wulong LeiHuan XuHao YaoLanjiao LiMenglei WangXiyuan ZhouXueqin LiuPublished in: Molecular medicine (Cambridge, Mass.) (2023)
5α-Hydroxycostic acid can inhibit choroidal neovascularization by interfering with the VEGF- and Ang2/Tie2-related pathways, and it may be a good candidate drug for treating CNV.